Thursday, April 25, 2024
Image
The Rapid Acceleration of Diagnostics (RADx) Tech program propelled production of COVID-19 tests in the US during the pandemic. Now firmly in the post-pandemic era, the program has pivoted to support other healthcare segments with diagnostic testing gaps, and has also begun to recapitulate its novel hybrid funding and support approach throughout the National Institutes of Health. The RADx Tech program is part of the NIH Blueprint MedTech program. NIH Blueprint MedTech utilizes the infrastructure and processes of the RADx Tech approach to accelerate device development for neurological disorders and conditions.